NO893764D0 - Fremgangsmaate til fremstilling av 1-((diarylmetoksy)alkyl)-pyrrolidiner og -piperidiner. - Google Patents
Fremgangsmaate til fremstilling av 1-((diarylmetoksy)alkyl)-pyrrolidiner og -piperidiner.Info
- Publication number
- NO893764D0 NO893764D0 NO893764A NO893764A NO893764D0 NO 893764 D0 NO893764 D0 NO 893764D0 NO 893764 A NO893764 A NO 893764A NO 893764 A NO893764 A NO 893764A NO 893764 D0 NO893764 D0 NO 893764D0
- Authority
- NO
- Norway
- Prior art keywords
- diarylmetoxy
- pyrrolidines
- piperidines
- alkyl
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- H—ELECTRICITY
- H03—ELECTRONIC CIRCUITRY
- H03H—IMPEDANCE NETWORKS, e.g. RESONANT CIRCUITS; RESONATORS
- H03H7/00—Multiple-port networks comprising only passive electrical elements as network components
- H03H7/01—Frequency selective two-port networks
- H03H7/09—Filters comprising mutual inductance
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8812430A FR2636946B1 (fr) | 1988-09-23 | 1988-09-23 | ((diarylmethoxy)alcoyl)-1 pyrrolidines et piperidines, procedes de preparation et medicaments les contenant |
Publications (2)
Publication Number | Publication Date |
---|---|
NO893764D0 true NO893764D0 (no) | 1989-09-22 |
NO893764L NO893764L (no) | 1990-03-26 |
Family
ID=9370298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO89893764A NO893764L (no) | 1988-09-23 | 1989-09-22 | Fremgangsmaate til fremstilling av 1-((diarylmetoksy)alkyl)-pyrrolidiner og -piperidiner. |
Country Status (25)
Country | Link |
---|---|
US (1) | US4957927A (no) |
EP (1) | EP0360685B1 (no) |
JP (1) | JPH02121964A (no) |
AR (1) | AR246255A1 (no) |
AT (1) | ATE101132T1 (no) |
AU (1) | AU617530B2 (no) |
CA (1) | CA1327364C (no) |
CZ (1) | CZ279282B6 (no) |
DD (1) | DD284875A5 (no) |
DE (1) | DE68912860T2 (no) |
DK (1) | DK468389A (no) |
ES (1) | ES2062071T3 (no) |
FR (1) | FR2636946B1 (no) |
HU (1) | HU208422B (no) |
IE (1) | IE63648B1 (no) |
IL (1) | IL91689A0 (no) |
MA (1) | MA21631A1 (no) |
NO (1) | NO893764L (no) |
NZ (1) | NZ230744A (no) |
OA (1) | OA09135A (no) |
PT (1) | PT91783B (no) |
SU (1) | SU1757462A3 (no) |
TN (1) | TNSN89103A1 (no) |
YU (1) | YU170189A (no) |
ZA (1) | ZA897212B (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9100517A (es) * | 1990-08-06 | 1992-04-01 | Smith Kline French Lab | Compuestos |
MX9100513A (es) * | 1990-08-06 | 1992-04-01 | Smith Kline French Lab | Compuestos |
TW230771B (no) * | 1990-08-09 | 1994-09-21 | Sankyo Co | |
GB9113031D0 (en) * | 1991-06-17 | 1991-08-07 | Smithkline Beecham Plc | Compounds |
US5578639A (en) * | 1994-07-01 | 1996-11-26 | Warner-Lambert Company | PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption |
US6201124B1 (en) | 1995-12-21 | 2001-03-13 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
US6153754A (en) * | 1995-12-21 | 2000-11-28 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
US5747523A (en) * | 1996-01-24 | 1998-05-05 | Guilford Pharmaceuticals Inc. | Substituted ethyl α,α-diarylmethyl ether derivatives |
US6011035A (en) * | 1998-06-30 | 2000-01-04 | Neuromed Technologies Inc. | Calcium channel blockers |
US6946475B1 (en) | 1999-04-07 | 2005-09-20 | University Of Virginia Patent Foundation | Anticancer calcium channel blockers |
DE60011755T2 (de) * | 1999-04-07 | 2005-06-30 | The University Of Virginia Patent Foundation | Calciumkanalblocker als antikrebsmittel |
US6930186B2 (en) * | 2001-06-13 | 2005-08-16 | Teva Pharmacetical Industries Ltd. | Process for the preparation of paroxetine substantially free of alkoxy impurities |
US9427429B2 (en) | 2010-03-01 | 2016-08-30 | Tau Therapeutics Llc | Cancer diagnosis and imaging |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1545094A (en) * | 1976-12-14 | 1979-05-02 | Gist Brocades Nv | Piperazine derivatives |
-
1988
- 1988-09-23 FR FR8812430A patent/FR2636946B1/fr not_active Expired - Lifetime
-
1989
- 1989-09-06 YU YU01701/89A patent/YU170189A/xx unknown
- 1989-09-19 AT AT89402561T patent/ATE101132T1/de not_active IP Right Cessation
- 1989-09-19 IL IL91689A patent/IL91689A0/xx not_active IP Right Cessation
- 1989-09-19 ES ES89402561T patent/ES2062071T3/es not_active Expired - Lifetime
- 1989-09-19 EP EP89402561A patent/EP0360685B1/fr not_active Expired - Lifetime
- 1989-09-19 DE DE68912860T patent/DE68912860T2/de not_active Expired - Fee Related
- 1989-09-20 MA MA21885A patent/MA21631A1/fr unknown
- 1989-09-20 JP JP1242360A patent/JPH02121964A/ja active Pending
- 1989-09-20 AR AR89314972A patent/AR246255A1/es active
- 1989-09-21 ZA ZA897212A patent/ZA897212B/xx unknown
- 1989-09-22 OA OA59651A patent/OA09135A/xx unknown
- 1989-09-22 US US07/410,705 patent/US4957927A/en not_active Expired - Fee Related
- 1989-09-22 DD DD89332899A patent/DD284875A5/de not_active IP Right Cessation
- 1989-09-22 AU AU41690/89A patent/AU617530B2/en not_active Ceased
- 1989-09-22 IE IE305089A patent/IE63648B1/en not_active IP Right Cessation
- 1989-09-22 PT PT91783A patent/PT91783B/pt not_active IP Right Cessation
- 1989-09-22 SU SU894742008A patent/SU1757462A3/ru active
- 1989-09-22 NO NO89893764A patent/NO893764L/no unknown
- 1989-09-22 DK DK468389A patent/DK468389A/da not_active Application Discontinuation
- 1989-09-22 NZ NZ230744A patent/NZ230744A/en unknown
- 1989-09-22 TN TNTNSN89103A patent/TNSN89103A1/fr unknown
- 1989-09-22 CZ CS895409A patent/CZ279282B6/cs unknown
- 1989-09-22 CA CA000612673A patent/CA1327364C/fr not_active Expired - Fee Related
- 1989-09-22 HU HU894981A patent/HU208422B/hu not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SU1757462A3 (ru) | 1992-08-23 |
AU4169089A (en) | 1990-03-29 |
MA21631A1 (fr) | 1990-04-01 |
JPH02121964A (ja) | 1990-05-09 |
DE68912860T2 (de) | 1994-08-11 |
IE893050L (en) | 1990-03-23 |
PT91783B (pt) | 1995-08-09 |
EP0360685A1 (fr) | 1990-03-28 |
US4957927A (en) | 1990-09-18 |
FR2636946A1 (fr) | 1990-03-30 |
FR2636946B1 (fr) | 1990-11-02 |
DK468389A (da) | 1990-03-24 |
YU170189A (en) | 1991-02-28 |
OA09135A (fr) | 1991-10-31 |
DK468389D0 (da) | 1989-09-22 |
PT91783A (pt) | 1990-03-30 |
NO893764L (no) | 1990-03-26 |
IE63648B1 (en) | 1995-05-31 |
CZ279282B6 (cs) | 1995-04-12 |
IL91689A0 (en) | 1990-06-10 |
EP0360685B1 (fr) | 1994-02-02 |
ES2062071T3 (es) | 1994-12-16 |
NZ230744A (en) | 1991-06-25 |
DD284875A5 (de) | 1990-11-28 |
CZ540989A3 (en) | 1994-11-16 |
AR246255A1 (es) | 1994-07-29 |
ATE101132T1 (de) | 1994-02-15 |
AU617530B2 (en) | 1991-11-28 |
ZA897212B (en) | 1991-03-27 |
HUT52049A (en) | 1990-06-28 |
HU208422B (en) | 1993-10-28 |
DE68912860D1 (de) | 1994-03-17 |
CA1327364C (fr) | 1994-03-01 |
TNSN89103A1 (fr) | 1991-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO891226L (no) | Fremgangsmaate til fremstilling av fotoherdede belegg. | |
NO894786L (no) | Fremgangsmaate for fremstilling av propenonoksimetere. | |
NO165143C (no) | Fremgangsmaate til fremstilling av hydrokloridet av fenyl-1-dietylaminokarbonyl-1-aminometyl-2-cyklopropan (z). | |
NO885454D0 (no) | Fremgangsmaate for fremstilling av triklormonosilan. | |
NO894210L (no) | Fremgangsmaate for fremstilling av kinolyloxazol-2-oner. | |
NO893764L (no) | Fremgangsmaate til fremstilling av 1-((diarylmetoksy)alkyl)-pyrrolidiner og -piperidiner. | |
NO158136C (no) | Fremgangsmaate til fremstilling av tiadiazolderivater. | |
NO894649D0 (no) | Fremgangsmaate for fremstilling av (s)-alfa-ethyl-2-oxo-1-pyrrolidinacetamid. | |
NO861486L (no) | Fremgangsmaate til fremstilling av fluorerte benzyltriazolforbindelser. | |
NO892204L (no) | Fremgangsmaate for fremstilling av imidazokinoxalin-forbindelser. | |
NO905444L (no) | Fremgangsmaate til fremstilling av oksazolderivater. | |
NO895032D0 (no) | Fremgangsmaate for fremstilling av 2-benzotiazoliner. | |
NO890159L (no) | Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler. | |
NO883145D0 (no) | Fremgangsmaate til fremstilling av tienoimidazolderivater. | |
NO901690D0 (no) | Fremgangsmaate til fremstilling av substituerte azetidinylisotiazolpyridon-derivater. | |
NO895040L (no) | Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer. | |
NO901422L (no) | Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer. | |
NO913720L (no) | Fremgangsmaate for fremstilling av 1-((2s)-3-mercapto-methyl-1-oxopropyl)-l-prolin. | |
NO880106D0 (no) | Fremgangsmaate til fremstilling av kalknitrogen. | |
NO883610D0 (no) | Fremgangsmaate til fremstilling av substituerte tienoimidazol-derivater. | |
NO892813D0 (no) | Fremgangsmaate til fremstilling av l-alanyl-l-prolin-derivater. | |
NO893357L (no) | Fremgangsmaate for fremstilling av fenylalkylthiofener. | |
NO890819L (no) | Fremgangsmaate for fremstilling av hydroksybenzaldehyder. | |
NO891004D0 (no) | Fremgangsmaate til fremstilling av 7-oksomitosan-derivater. | |
NO870026D0 (no) | Fremgangsmaate til fremstilling av trisubstituerte triazoler. |